VRX Silica Quote - VRX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.06

Bid

0.059

Offer

0.06

Volume

1,518,022

0.06 Day's Range 0.063

0.026 52 Week Range 0.12

Market Cap

35.003M

Previous Close

0.06

Open

0.062

Last Trade

1171

0.059

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

422,789

Shares Outstanding

583,378,548

Dividend Yield

PE Ratio

-8.22

Earnings Per Share (EPS)

-0.01

Revenue

Net Profit

-4.26M

Sector

Miscellaneous Metal Ores,nec

Industry

Miscellaneous Metal Ores,nec

Website

www.vrxsilica.com.au

Headquarters

Perth, Western Australia, Aus

Founded

VRX Silica Limited is listed in the Miscellaneous Metal Ores sector of the Australian Stock Exchange with ticker VRX. The last closing price for VRX Silica was AUD0.06. Over the last year, VRX Silica shares have traded in a share price range of AUD 0.026 to AUD 0.12.

VRX Silica currently has 583,378,548 shares in issue. The market capitalisation of VRX Silica is AUD35 million. VRX Silica has a price to earnings ratio (PE ratio) of -8.22.

Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010

ALISO VIEJO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that it will host a conference call and a live Internet webcast along with...

FDA Accepts NDA Filing for Retigabine

MAA successfully validated by EMEA ALISO VIEJO, Calif., Dec. 30 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that the U.S. Food and Drug...

Critical Alerts for AIG, Baidu.com, PPG, Jefferies Group, and Valeant Pharmaceuticals Released by Seven Summits Research

CHICAGO, Nov. 24 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AIG, BIDU, PPG, JEF, and VRX. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of

ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE:VRX) today announced that results from the week-72 analysis for its Phase IIb dose-finding clinical trial for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	50	0.04	0.063	0.039	1929162	0.0522283	DE
4	0.019	46.3414634146	0.041	0.063	0.037	668765	0.04715219	DE
12	0.032	114.285714286	0.028	0.063	0.026	422789	0.04126929	DE
26	0.001	1.69491525424	0.059	0.063	0.026	439077	0.03950259	DE
52	-0.045	-42.8571428571	0.105	0.12	0.026	326089	0.05314861	DE
156	-0.11	-64.7058823529	0.17	0.225	0.026	314858	0.1138846	DE
260	-0.055	-47.8260869565	0.115	0.425	0.026	515299	0.1783498	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OECROrbital Corporation Limited	AUD 0.002 (100.00%)	6.95k
VPRVolt Group Ltd	AUD 0.0015 (50.00%)	3.24M
EWCEnergy World Corporation Ltd	AUD 0.023 (43.75%)	2.96M
PCLOPancontinental Energy NL	AUD 0.01 (42.86%)	3M
RMLResolution Minerals Ltd	AUD 0.002 (33.33%)	54.04k
ADNOCAndromeda Metals Limited	AUD 0.001 (-50.00%)	10.75M
RBRRBR Group Limited	AUD 0.001 (-50.00%)	5M
MTLMantle Minerals Limited	AUD 0.001 (-33.33%)	5.48M
EUROEuropean Lithium Limited	AUD 0.004 (-33.33%)	250k
ARDOArgent Minerals Ltd	AUD 0.002 (-33.33%)	1.41M
OVTOvanti Ltd	AUD 0.024 (-7.69%)	77.18M
CDECodeifai Ltd	AUD 0.001 (0.00%)	70.55M
SYASayona Mining Limited	AUD 0.035 (2.94%)	57.28M
PLSPilbara Minerals Limited	AUD 2.60 (-5.45%)	55.05M
TMKTMK Energy Ltd	AUD 0.0025 (25.00%)	46.43M